株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の幹細胞バンキング市場

Stem Cell Banking

発行 Global Industry Analysts, Inc. 商品コード 909092
出版日 ページ情報 英文 289 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.69円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

世界の幹細胞バンキング市場 Stem Cell Banking
出版日: 2020年07月01日 ページ情報: 英文 289 Pages
概要

当レポートでは、世界の幹細胞バンキング市場について調査し、市場の動向と企業・セグメント別のシェア、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

  • 市場概要
    • 競合企業の市場シェア
    • 市場シェアシナリオ
    • セグメント別市場シェア
    • 胎盤幹細胞
    • 脂肪組織由来幹細胞
    • 骨髄由来幹細胞
    • ヒト胚由来幹細胞
    • 歯髄由来幹細胞
    • 試料保存・保管
    • 試料プロセシング
    • 試料分析
    • 試料採取・輸送
  • 注目企業
  • 市場動向と促進因子
  • 世界市場見通し

第3章 市場分析

  • 地域別市場の分析およびシェアの予測
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • アジア太平洋地域
  • その他の諸国

第4章 競合

  • CORD BLOOD REGISTRY
  • CORDLIFE GROUP
  • CRYO-CELL INTERNATIONAL
  • CRYO-SAVE AG
  • GLOBAL CORD BLOOD CORPORATION
  • LIFECELL INTERNATIONAL PVT.
  • SMART CELLS INTERNATIONAL
  • STEMCYTE
  • VIACORD
  • VITA 34 AG

第5章 関連調査

目次
Product Code: MCP15021

The global market for Stem Cell Banking is projected to reach US$9.9 billion by 2025, driven by their growing importance in medicine given their potential to regenerate and repair damaged tissue. Stem cells are defined as cells with the potential to differentiate and develop into different types of cells. Different accessible sources of stem cells include embryonic stem cells, fetal stem cells, peripheral blood stem cells, umbilical cord stem cells, mesenchymal stem cells (bmMSCs) and induced pluripotent stem cells. Benefits of stem cells include ability to reverse diseases like Parkinson's by growing new, healthy and functioning brain cells; heal and regenerate tissues and muscles damaged by heart attack; address genetic defects by introducing normal cells; reduce mortality among patients awaiting donor organs for transplant by regenerating healthy cells and tissues as an alternative to donated organs. While currently valuable in bone marrow transplantation, stem cell therapy holds huge potential in treating a host of common chronic diseases such as diabetes, heart disease (myocardial infarction), Parkinson's disease, spinal cord injury, arthritis, and amyotrophic lateral sclerosis. The technology has the potential to revolutionize public health. The growing interest in regenerative medicine which involves replacing, engineering or regenerating human cells, tissues or organs, will push up the role of stem cells. Developments in stem cells bioprocessing are important and will be key factor that will influence and help regenerative medicine research move into real-world clinical use. The impact of regenerative medicine on healthcare will be comparable to the impact of antibiotics, vaccines, and monoclonal antibodies in current clinical care. With global regenerative medicine market poised to reach over US$45 billion 2025, demand for stem cells will witness robust growth.

Another emerging application area for stem cells is in drug testing in the pharmaceutical field. New drugs in development can be safely, accurately, and effectively be tested on stem cells before commencing tests on animal and human models. Among the various types of stem cells, umbilical cord stem cells are growing in popularity as they are easy and safe to extract. After birth blood from the umbilical cord is extracted without posing risk either to the mother or the child. As compared to embryonic and fetal stem cells which are saddled with safety and ethical issues, umbilical cord is recovered postnatally and is today an inexpensive and valuable source of multipotent stem cells. Until now discarded as waste material, umbilical cord blood is today acknowledged as a valuable source of blood stem cells. The huge gap between newborns and available cord blood banks reveals huge untapped opportunity for developing and establishing a more effective banking system for making this type of stem cells viable for commercial scale production and supply. Umbilical cord and placenta contain haematopoietic blood stem cells (HSCs). These are the only cells capable of producing immune system cells (red cells, white cells and platelet). HSCs are valuable in the treatment of blood diseases and successful bone marrow transplants. Also, unlike bone marrow stem cells, umbilical cord blood has the advantage of having "off-the-shelf" uses as it requires no human leukocyte antigen (HLA) tissue matching. Developments in stem cell preservation will remain crucial for successful stem cell banking. Among the preservation technologies, cryopreservation remains popular. Development of additives for protecting cells from the stresses of freezing and thawing will also be important for the future of the market. The United States and Europe represent large markets worldwide with a combined share of 60.5% of the market. China ranks as the fastest growing market with a CAGR of 10.8% over the analysis period supported by the large and growing network of umbilical cord blood banks in the country. The Chinese government has, over the years, systematically nurtured the growth of umbilical cord blood (UCB) banks under the "Developmental and Reproductive Research Initiation" program launched in 2008. Several hybrid public-private partnerships and favorable governmental licensing policies today are responsible for the current growth in this market.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Stem Cells, Application Areas, and the Different Types - A Prelude
  • Applications of Stem Cells
  • Types of Stem Cells
  • Cord Blood
  • Umbilical Cord Tissue
  • Bone Marrow Stem Cells
  • Adipose-Derived Stem Cells (ADSCs)
  • Number of Clinical Trials Using Adipose Stem Cells: 2007-2018
  • Number of Adipose Stem Cell Trials by Phase: 2007 to 2018
  • Human Embryo-Derived Stem Cells (HESCS)
  • Global Stem Cell Banking Market Poised for a Rapid Growth
  • Developed Regions Lead, Emerging Economies to Spearhead Future Growth
  • List of Family Cord Blood Banks in the US
  • Placental and Cord Blood Banks Dominate the Cord Blood Banking Market
  • Global Number of Annual Newborns and Private Cord Blood Banks
  • Global Select Leading Cord Blood Banks Based on Inventory
  • A Peek into China's Cord Blood Banking Industry
  • Evolving Landscape of Cord Blood Banking Industry
  • Placental Stem Cells and Potential Clinical Applications
  • Global Cord Blood Banking Market Share Breakdown (%) by Bank Type: 2019
  • US Cord Blood Banking Market by Bank Type (in %) for 2019
  • Changing Business Models for Stem Cell Banking
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Cord Blood Registry (CBR) Systems, Inc. (USA)
  • Cordlife Group Limited (Singapore)
  • Cryo Stemcell Private Limited (India)
  • Cryo-Cell International, Inc. (USA)
  • Cryoviva Biotech Private Limited (India)
  • Global Cord Blood Corporation (China)
  • LifeCell International Pvt. Ltd (India)
  • Smart Cells International Ltd. (UK)
  • StemCyte (USA)
  • Takara Bio Europe AB (Europe)
  • ViaCord (US)
  • Vita34 AG (Germany)

3. MARKET TRENDS & DRIVERS

  • Increasing Investments in Stem Cell-Based Research Widen Prospects for Stem Cell Banking Market
  • Stem Cell Research Funding in the US (in US$ Million) for the Years 2011 through 2017
  • Stem Cell Research Policies Impact Funding Volumes
  • Adult Stem Cell Research Gains Traction, Accelerating Research Funding
  • Adult Stem Cells Vs. Embryonic Stem Cells: A Comparison
  • Embryonic Stem Cell Research Bogged Down by Ethical Issues & Technical Hurdles
  • Induced Pluripotent Stem Cell (iPSC) Research: The Latest Vertical
  • Sustained Emphasis on Mesenchymal Stem Cell Research
  • Emergence of Advanced Technologies for Stem Cell Preservation, Storage and Processing Augurs Well for Market Growth
  • Growing Incidence of Major Diseases to Boost the Demand for Stem Cells, Driving Stem Cell Banking
  • Worldwide Incidence of Cancer (2012, 2018 & 2040): Number of New Cases Diagnosed
  • World Cancer Incidence by Cancer Type (2018): Number of New Cancer Cases Reported (in Thousands) for Breast, Cervix uteri, Colorectum, Liver, Lung, Oesophagus, Prostate, Stomach and Others
  • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Ageing Demographics to Drive Demand for Stem Cell Banking
  • Global Aging Population Statistics - Opportunity Indicators
  • Elderly Population (60+ Years) as a Percentage of Total Population (2017 & 2050)
  • Global Aging Population (2017 & 2050): Population of 60+ Individuals in '000s and as a Percentage of Total Population
  • Life Expectancy for Select Countries in Number of Years: 2018
  • Bone Marrow Stem Cells Market on a Rapid Growth Path, Spurring the Need for Stem Cell Banking
  • Development of Regenerative Medicine Accelerates Demand for Mesenchymal Stem Cell Banking
  • Global Regenerative Medicines Market by Category (2019): Percentage Breakdown for Biomaterials, Stem Cell Therapies and Tissue Engineering
  • Rise in Volume of Orthopedic Procedures Boosts Prospects for Stem Cell Banking
  • Global Orthopedic Surgical Procedure Volume (2010-2020) (in Million)
  • Increasing Demand for Stem Cell Based Bone Grafts: Promising Growth Ahead for Stem Cell Banking
  • Rise in the Number of Hematopoietic Stem Cell Transplantation Procedures Propels Market Expansion
  • Hematopoietic Stem Cell Storage
  • Dental Mesenchymal Stem Cells: An Evolving Niche
  • Therapeutic Potential of Dental Pulp Stem Cells (DPSCs) in Various Diseases
  • High Operational Costs of Stem Cell Banking - A Key Market Restraint

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Stem Cell Banking Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Stem Cell Banking Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Placental and Cord Blood Stem Cells (Source) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 4: Placental and Cord Blood Stem Cells (Source) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Adipose Tissue-Derived Stem Cells (ADSCS) (Source) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 6: Adipose Tissue-Derived Stem Cells (ADSCS) (Source) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: Bone Marrow-Derived Stem Cells (BMSCS) (Source) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Bone Marrow-Derived Stem Cells (BMSCS) (Source) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 9: Human Embryo-Derived Stem Cells (HESCS) (Source) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 10: Human Embryo-Derived Stem Cells (HESCS) (Source) Market Share Breakdown by Region/Country: 2020 VS 2027
  • TABLE 11: Dental Pulp-Derived Stem Cells (DPSCS) (Source) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 12: Dental Pulp-Derived Stem Cells (DPSCS) (Source) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 13: Other Stem Cell Sources (Source) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
  • TABLE 14: Other Stem Cell Sources (Source) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
  • TABLE 15: Sample Preservation and Storage (Service Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
  • TABLE 16: Sample Preservation and Storage (Service Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 17: Sample Analysis (Service Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 18: Sample Analysis (Service Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 19: Sample Processing (Service Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 20: Sample Processing (Service Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 21: Sample Collection and Transportation (Service Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 22: Sample Collection and Transportation (Service Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 23: Personalized Banking Applications (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 24: Personalized Banking Applications (Application) Distribution of Global Sales by Region/Country: 2020 VS 2027
  • TABLE 25: Research Applications (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 26: Research Applications (Application) Global Market Share Distribution by Region/Country for 2020 and 2027
  • TABLE 27: Clinical Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 28: Clinical Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • TABLE 29: United States Stem Cell Banking Market Estimates and Projections in US$ Million by Source: 2020 to 2027
    • TABLE 30: United States Stem Cell Banking Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 31: United States Stem Cell Banking Market Estimates and Projections in US$ Million by Service Type: 2020 to 2027
    • TABLE 32: United States Stem Cell Banking Market Share Breakdown by Service Type: 2020 VS 2027
    • TABLE 33: United States Stem Cell Banking Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
    • TABLE 34: Stem Cell Banking Market Share Breakdown in the United States by Application: 2020 VS 2027
  • CANADA
    • TABLE 35: Canadian Stem Cell Banking Market Estimates and Forecasts in US$ Million by Source: 2020 to 2027
    • TABLE 36: Stem Cell Banking Market in Canada: Percentage Share Breakdown of Sales by Source for 2020 and 2027
    • TABLE 37: Canadian Stem Cell Banking Market Estimates and Forecasts in US$ Million by Service Type: 2020 to 2027
    • TABLE 38: Stem Cell Banking Market in Canada: Percentage Share Breakdown of Sales by Service Type for 2020 and 2027
    • TABLE 39: Canadian Stem Cell Banking Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 40: Canadian Stem Cell Banking Market Share Analysis by Application: 2020 VS 2027
  • JAPAN
    • TABLE 41: Japanese Market for Stem Cell Banking: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020-2027
    • TABLE 42: Japanese Stem Cell Banking Market Share Analysis by Source: 2020 VS 2027
    • TABLE 43: Japanese Market for Stem Cell Banking: Annual Sales Estimates and Projections in US$ Million by Service Type for the Period 2020-2027
    • TABLE 44: Japanese Stem Cell Banking Market Share Analysis by Service Type: 2020 VS 2027
    • TABLE 45: Japanese Demand Estimates and Forecasts for Stem Cell Banking in US$ Million by Application: 2020 to 2027
    • TABLE 46: Stem Cell Banking Market Share Shift in Japan by Application: 2020 VS 2027
  • CHINA
    • TABLE 47: Chinese Stem Cell Banking Market Growth Prospects in US$ Million by Source for the Period 2020-2027
    • TABLE 48: Chinese Stem Cell Banking Market by Source: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 49: Chinese Stem Cell Banking Market Growth Prospects in US$ Million by Service Type for the Period 2020-2027
    • TABLE 50: Chinese Stem Cell Banking Market by Service Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 51: Chinese Demand for Stem Cell Banking in US$ Million by Application: 2020 to 2027
    • TABLE 52: Chinese Stem Cell Banking Market Share Breakdown by Application: 2020 VS 2027
  • EUROPE
    • TABLE 53: European Stem Cell Banking Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 54: European Stem Cell Banking Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 55: European Stem Cell Banking Market Estimates and Forecasts in US$ Million by Source: 2020-2027
    • TABLE 56: European Stem Cell Banking Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 57: European Stem Cell Banking Market Estimates and Forecasts in US$ Million by Service Type: 2020-2027
    • TABLE 58: European Stem Cell Banking Market Share Breakdown by Service Type: 2020 VS 2027
    • TABLE 59: European Stem Cell Banking Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 60: European Stem Cell Banking Market Share Analysis by Application: 2020 VS 2027
  • FRANCE
    • TABLE 61: Stem Cell Banking Market in France by Source: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 62: French Stem Cell Banking Market Share Analysis by Source: 2020 VS 2027
    • TABLE 63: Stem Cell Banking Market in France by Service Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 64: French Stem Cell Banking Market Share Analysis by Service Type: 2020 VS 2027
    • TABLE 65: Stem Cell Banking Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
    • TABLE 66: French Stem Cell Banking Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • GERMANY
    • TABLE 67: Stem Cell Banking Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Source for the Period 2020-2027
    • TABLE 68: German Stem Cell Banking Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 69: Stem Cell Banking Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Service Type for the Period 2020-2027
    • TABLE 70: German Stem Cell Banking Market Share Breakdown by Service Type: 2020 VS 2027
    • TABLE 71: Stem Cell Banking Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
    • TABLE 72: Stem Cell Banking Market Share Distribution in Germany by Application: 2020 VS 2027
  • ITALY
    • TABLE 73: Italian Stem Cell Banking Market Growth Prospects in US$ Million by Source for the Period 2020-2027
    • TABLE 74: Italian Stem Cell Banking Market by Source: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 75: Italian Stem Cell Banking Market Growth Prospects in US$ Million by Service Type for the Period 2020-2027
    • TABLE 76: Italian Stem Cell Banking Market by Service Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 77: Italian Demand for Stem Cell Banking in US$ Million by Application: 2020 to 2027
    • TABLE 78: Italian Stem Cell Banking Market Share Breakdown by Application: 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 79: United Kingdom Market for Stem Cell Banking: Annual Sales Estimates and Projections in US$ Million by Source for the Period 2020-2027
    • TABLE 80: United Kingdom Stem Cell Banking Market Share Analysis by Source: 2020 VS 2027
    • TABLE 81: United Kingdom Market for Stem Cell Banking: Annual Sales Estimates and Projections in US$ Million by Service Type for the Period 2020-2027
    • TABLE 82: United Kingdom Stem Cell Banking Market Share Analysis by Service Type: 2020 VS 2027
    • TABLE 83: United Kingdom Demand Estimates and Forecasts for Stem Cell Banking in US$ Million by Application: 2020 to 2027
    • TABLE 84: Stem Cell Banking Market Share Shift in the United Kingdom by Application: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Stem Cell Banking Market Estimates and Forecasts in US$ Million by Source: 2020-2027
    • TABLE 86: Rest of Europe Stem Cell Banking Market Share Breakdown by Source: 2020 VS 2027
    • TABLE 87: Rest of Europe Stem Cell Banking Market Estimates and Forecasts in US$ Million by Service Type: 2020-2027
    • TABLE 88: Rest of Europe Stem Cell Banking Market Share Breakdown by Service Type: 2020 VS 2027
    • TABLE 89: Rest of Europe Stem Cell Banking Addressable Market Opportunity in US$ Million by Application: 2020-2027
    • TABLE 90: Rest of Europe Stem Cell Banking Market Share Analysis by Application: 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 91: Stem Cell Banking Market in Asia-Pacific by Source: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 92: Asia-Pacific Stem Cell Banking Market Share Analysis by Source: 2020 VS 2027
    • TABLE 93: Stem Cell Banking Market in Asia-Pacific by Service Type: Estimates and Projections in US$ Million for the Period 2020-2027
    • TABLE 94: Asia-Pacific Stem Cell Banking Market Share Analysis by Service Type: 2020 VS 2027
    • TABLE 95: Stem Cell Banking Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
    • TABLE 96: Asia-Pacific Stem Cell Banking Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027
  • REST OF WORLD
    • TABLE 97: Rest of World Stem Cell Banking Market Estimates and Forecasts in US$ Million by Source: 2020 to 2027
    • TABLE 98: Stem Cell Banking Market in Rest of World: Percentage Share Breakdown of Sales by Source for 2020 and 2027
    • TABLE 99: Rest of World Stem Cell Banking Market Estimates and Forecasts in US$ Million by Service Type: 2020 to 2027
    • TABLE 100: Stem Cell Banking Market in Rest of World: Percentage Share Breakdown of Sales by Service Type for 2020 and 2027
    • TABLE 101: Rest of World Stem Cell Banking Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
    • TABLE 102: Rest of World Stem Cell Banking Market Share Analysis by Application: 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 78